Dr. Jason Robert Guertin is a researcher at the Centre de recherche du CHU de Québec – Laval University and an assistant professor in the Department of Preventive and Social Medicine of Université Laval’s Faculty of Medicine.

Financial evaluation is a pivotal component of health technology assessment. It aims to support decision-makers to establish if adopting a novel health technology represents the most efficient use of available resources. Considering that healthcare demands are continuously on the rise, and budgets are overstretched, many health technology assessment units in Canada and abroad are examining the option of reassessing the value of previously adopted technologies using observational economic revaluations. Dr. Guertin’s research program focuses on the various components of economic evaluations and revaluations conducted within an observational setting. More recently, his work has focused on: 1) the development of novel methods aimed at addressing limits associated with observational economic evaluations; 2) evaluating the impact of chronic diseases on patients’ health-related quality of life in Quebec and Canada; and 3) the economic evaluation of health technologies in the field of personalized medicine.

Hôpital Saint-Sacrement
1050 Chemin Sainte-Foy
J1-09B
Québec, QC
Canada G1S 4L8
48 entries « 4 of 5 »

Azzi L, Beauchamp C, Bogaty P, Boothroyd L, Carroll C, Désy F, Dussault H, Guertin J, Lambert L, Sas G

Portrait de l’utilisation et des résultats cliniques de l’implantation valvulaire aortique par cathéter (TAVI) au Québec : résultats d’une évaluation sur le terrain à l’échelle provinciale en 2013-2015

Book

Institut national d’excellence en santé et en services sociaux (INESSS), Québec, QC, 2016, ISBN: 978-2-550-75480-0 (PDF).

Mitchell D, Guertin JR, Iliza AC, LeLorier J

Economic Evaluation Of A Pharmacogenomic Test For Statin-Induced Myopathy In Cardiovascular High-Risk Patients Initiating A Statin.

Journal Article

Value Health, 18 (7), pp. A396, 2015, ISSN: 1098-3015.

| Links:

Guertin JR, Bowen JM, O'Reilly D, Tarride J

Propensity Score Matching Does not Always Remove Confounding within an Economic Evaluation Based on a Non-Randomized Study.

Journal Article

Value Health, 18 (7), pp. A338, 2015, ISSN: 1098-3015.

| Links:

Guertin JR, Mitchell D, Ali F, LeLorier J

Bias within economic evaluations - the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug.

Journal Article

Clinicoecon Outcomes Res, 7 , pp. 497-503, 2015, ISSN: 1178-6981.

Abstract | Links:

Ouellet E, Durand M, Guertin JR, LeLorier J, Tremblay CL

Cost effectiveness of 'on demand' HIV pre-exposure prophylaxis for non-injection drug-using men who have sex with men in Canada.

Journal Article

Can J Infect Dis Med Microbiol, 26 (1), pp. 23-9, 2015, ISSN: 1712-9532.

Abstract | Links:

Boothroyd LJ, Lambert LJ, Ducharme A, Guertin JR, Sas G, Charbonneau E, Carrier M, Cecere R, Morin JE, Bogaty P

Challenge of informing patient decision making: what can we tell patients considering long-term mechanical circulatory support about outcomes, daily life, and end-of-life issues?

Journal Article

Circ Cardiovasc Qual Outcomes, 7 (1), pp. 179-87, 2014, ISSN: 1941-7713.

| Links:

Guertin J, LeLorier J, Durand M, Gow R, Holbrook A, Levine M

Impact of a restrictive drug access program on the risk of cardiovascular encounters in children exposed to ADHD medications.

Journal Article

J Popul Ther Clin Pharmacol, 21 (3), pp. e357-69, 2014.

Abstract | Links:

Lambert L, Sas G, Sanscartier C, Azzi L, Boothroyd L, Guertin J, Morin JE, Bogaty P

L’utilisation des dispositifs d’assistance ventriculaire gauche de longue durée pour le traitement de l’insuffisance cardiaque avancée au Québec de 2010 à 2012

Book

Institut national d’excellence en santé et en services sociaux (INESSS), Québec, QC, 2014, ISBN: 978-2-550-72095-9 (PDF).

Boothroyd LJ, Lambert LJ, Sas G, Guertin JR, Ducharme A, Charbonneau E, Carrier M, Cecere R, Morin JE, Bogaty P

Should eligibility for heart transplantation be a requirement for left ventricular assist device use? Recommendations based on a systematic review.

Journal Article

Can J Cardiol, 29 (12), pp. 1712-20, 2013, ISSN: 0828-282X.

Abstract | Links:

Poulin F, Khairy P, Roy D, Levesque S, Talajic M, Guertin JR, Lelorier J, Atrial Fibrillation, Congestive Heart Failure Trial Investigators

Atrial fibrillation and congestive heart failure: a cost analysis of rhythm-control vs. rate-control strategies.

Journal Article

Can J Cardiol, 29 (10), pp. 1256-62, 2013, ISSN: 0828-282X.

Abstract | Links:

48 entries « 4 of 5 »
Signaler des ajouts ou des modifications

Active projects

  • Audit & Feedback Module Targeting Low-Value Clinical Practices in Injury Care: an Economic Evaluation, Subvention, Instituts de recherche en santé du Canada, Subvention Projet, from 2020-04-01 to 2023-03-31
  • Canadian Program for Monitoring Overuse in Injury Care, Subvention, Instituts de recherche en santé du Canada, Subventions Fondation, from 2016-07-01 to 2021-06-30
  • Coûts des maladies cardiovasculaires et des problèmes de santé mentale attribuables aux contraintes psychosociales au travail : Une étude longitudinale de 22 ans auprès de 9 000 cols blancs., Subvention, Instituts de recherche en santé du Canada, Volet Projet: Concours pilotes, from 2016-07-01 to 2021-03-31
  • How to better manage infectious diseases in ER by triage with molecular mini-panels for the rapid detection of highly transmissible pathogens, Subvention, Consortium québécois sur la découverte du médicament, from 2018-10-01 to 2022-09-30
  • Optimisation des approches méthodologiques utilisées dans le cadre d’évaluations économiques basées sur des données observationnelles, Subvention, Fonds de recherche du Québec - Santé, Chercheur-boursier Juniors 1 et 2, Seniors, from 2019-07-01 to 2023-06-30
  • Optimisation des approches méthodologiques utilisées dans le cadre d’évaluations économiques basées sur des données observationnelles, Subvention, Fonds de recherche du Québec - Santé, Établissement de jeunes chercheurs - Juniors 1, from 2019-07-01 to 2023-06-30
  • PEGASUS-2 - PErsonalized Genomics for prenatal Abnormalities Screening USing maternal blood : Towards First Tier Screening and Beyond, Partenariat, Génome Canada, Projets de recherche appliquée à grande échelle - Large-Scale Applied Research Project, from 2018-04-01 to 2022-03-31
  • Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast, Subvention, Instituts de recherche en santé du Canada, Subvention Projet, from 2019-10-01 to 2022-02-28
  • Programme de soutien aux nouveaux chercheurs, Subvention, Université Laval - démarrage nouveau chercheur, Soutien facultaire aux jeunes chercheurs de la Faculté de médecine, from 2019-07-01 to 2022-06-30
  • Real-World Evaluation of the Efficacy, Safety and Cost-Effectiveness of Statins for Primary Prevention of Cardiovascular Disease Among the Elderly – A Causal Perspective to Treatment Trajectory Analysis, Subvention, Instituts de recherche en santé du Canada, Subvention Projet, from 2019-10-01 to 2023-03-31
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, Subvention, Instituts de recherche en santé du Canada, Subvention Projet, from 2020-04-01 to 2021-03-31

Recently finished projects

  • Clinical validity and clinical utility of a screening test for Paget's disease of bone, Subvention, Instituts de recherche en santé du Canada, Subvention Projet, from 2019-03-01 to 2020-03-31
  • Evolution in direct healthcare costs following an acute myocardial infarct in Quebec over a 20-year period, Subvention, Fonds de recherche du Québec - Santé, Réseaux thématiques de recherche, from 2019-04-01 to 2020-03-31
  • Financement d'un complément de bourse , Subvention, Fondation du CHU de Québec, from 2019-07-24 to 2020-03-31
  • Projet d'évaluation de la personnalisation des soins pharmaceutiques (PEPS) en centre d'hébergement de soins de longue durée (CHSLD), Subvention, Ministère de la Santé et des Services sociaux, from 2018-05-11 to 2019-06-30
  • Real-World Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation: A Canadian Health Technology Reassessment Study, Subvention, Instituts de recherche en santé du Canada, Subvention Projet, from 2018-04-01 to 2020-03-31
Data provided by the Université Laval research projects registery